The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 2018 Feb 13; 9(12):10497-10509.